Skip to main content
SpringerLink
Log in

Beliefs and Adherence in Hypertension and Cardiovascular Protection

  • Chapter
  • First Online:
Drug Adherence in Hypertension and Cardiovascular Protection

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

Abstract

Medication adherence is key to achieving good outcomes in hypertension and cardiovascular disease. However, adherence to preventive treatments remains poor with less than 50% of people adhering to treatment as prescribed. Many people do not even begin taking the medication, and even when treatment is initiated, early discontinuation is common. There have been many adherence interventions developed to promote adherence; however, the effectiveness of these have been limited. This chapter summarises the evidence to date on interventions to promote adherence and discusses the importance of approaching adherence from the individual patient perspective. A Perceptions and Practicalities Approach to designing and delivering interventions is then described, which outlines a pragmatic method for clinicians to adopt to encourage medication adherence. Explanations of how to implement this in practice, as well as factors to consider when designing adherence interventions, are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  3. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Falvey H, Vincze G, Klungel OH, et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin. 2008;24(1):121–7.

    Article  PubMed  Google Scholar 

  4. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284–90.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–7.e1.

    Article  PubMed  Google Scholar 

  6. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–8.

    Article  CAS  PubMed  Google Scholar 

  7. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–36.

    Article  PubMed  Google Scholar 

  8. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Esposti LD, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47–54.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–605.

    Article  CAS  PubMed  Google Scholar 

  11. De Vera MA, Bhole V, Burns LC, Lacaille D. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014;78(4):684–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dragomir A, Cote R, Roy L, Blais L, Lalonde L, Berard A, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–25.

    Article  PubMed  Google Scholar 

  13. Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH. The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med. 2013;126(4):357.e7–e27.

    Article  Google Scholar 

  14. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;(11):CD000011.

    Google Scholar 

  15. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1(7972):1265–8.

    Article  CAS  PubMed  Google Scholar 

  16. Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Horne R, Weinman J, Barber N, Elliott R, Morgan M, Cribb A. Concordance, adherence and compliance in medicine taking: report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). London: NCCSDO; 2005.

    Google Scholar 

  18. Nunes V, Neilson J, O’Flynn N, Calvert N, Kuntze S, Smithson H, et al. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Institute for Health and Clinical Excellence; 2009.

    Google Scholar 

  19. Conn VS, Ruppar TM, Chase JA, Enriquez M, Cooper PS. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep. 2015;17(12):94.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, et al. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc. 2012;52(3):381–97.

    Article  Google Scholar 

  21. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13(1):10–24.

    Article  CAS  PubMed  Google Scholar 

  22. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens. 2005;23(11):2101–7.

    Article  PubMed  Google Scholar 

  23. Shah NR, Hirsch AG, Zacker C, Wood GC, Schoenthaler A, Ogedegbe G, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22(4):392–6.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18(9):607–13.

    Article  CAS  PubMed  Google Scholar 

  26. Stack RJ, Elliott RA, Noyce PR, Bundy C. A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Diabet Med. 2008;25(10):1204–10.

    Article  CAS  PubMed  Google Scholar 

  27. Michie S, Johnston M, Francis J, Hardeman W, Eccles M. From theory to intervention: mapping theoretically derived behavioural determinants to behaviour change techniques. Appl Psychol. 2008;57(4):660–80.

    Article  Google Scholar 

  28. Piette JD, Heisler M, Horne R, Alexander GC. A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures. Soc Sci Med. 2006;62(4):846–57.

    Article  PubMed  Google Scholar 

  29. Fogg BJ, editor. A behavior model for persuasive design. In: Proceedings of the 4th international conference on persuasive technology, ACM; 2009.

    Google Scholar 

  30. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010;25(11):1172–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Vervloet M, Linn AJ, Van Weert J, De Bakker DH, Bouvy ML, Van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19(5):696–704.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.

    Article  Google Scholar 

  34. Bloom BS. Daily regimen and compliance with treatment: fewer daily doses and drugs with fewer side effects improve compliance. BMJ. 2001;323(7314):647.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Marešová V, et al. Risk factors for nonadherence to antihypertensive treatment—novelty and significance. Hypertension. 2017;69(6):1113–20.

    Article  CAS  PubMed  Google Scholar 

  36. Horne R, Chapman S, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Horne R, Clatworthy J. Adherence to advice and treatment. Health psychology. 2nd ed. Chichester: British Psychological Society and Blackwell Publishing Ltd; 2010. p. 175–88.

    Google Scholar 

  38. Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Sociol Health Illn. 1988;10(4):561–78.

    Article  Google Scholar 

  39. Andrade JP, Vilas-Boas F, Chagas H, Andrade M. Epidemiological aspects of adherence to the treatment of hypertension. Arq Bras Cardiol. 2002;79(4):380.

    Article  Google Scholar 

  40. Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H, Leventhal E, et al. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br J Health Psychol. 2013;18(1):18–30.

    Article  PubMed  Google Scholar 

  41. Heller MK, Chapman SC, Horne R. Beliefs about medication predict the misattribution of a common symptom as a medication side effect—evidence from an analogue online study. J Psychosom Res. 2015;79(6):519–29.

    Article  PubMed  Google Scholar 

  42. Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin Pharmacol Therap. 2011;90(5):722–6.

    Article  CAS  Google Scholar 

  43. Rose LE, Kim MT, Dennison CR, Hill MN. The contexts of adherence for African Americans with high blood pressure. J Adv Nurs. 2000;32(3):587–94.

    Article  CAS  PubMed  Google Scholar 

  44. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy*. Am J Hypertens. 2006;19(11):1190–6.

    Article  PubMed  Google Scholar 

  45. Richardson MA, Simons-Morton B, Annegers JF. Effect of perceived barriers on compliance with antihypertensive medication. Health Educ Q. 1993;20(4):489–503.

    Article  CAS  PubMed  Google Scholar 

  46. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160(1):31–7.

    PubMed  PubMed Central  CAS  Google Scholar 

  47. Tedla YG, Bautista LE. Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens. 2016;29(6):772–9.

    Article  PubMed  Google Scholar 

  48. Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F. Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull World Health Organ. 2002;80(1):33–9.

    PubMed  PubMed Central  Google Scholar 

  49. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171(9):814–22.

    PubMed  Google Scholar 

  50. Boeni F, Spinatsch E, Suter K, Hersberger KE, Arnet I. Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Syst Rev. 2014;3(1):29.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Gollwitzer PM, Brandstätter V. Implementation intentions and effective goal pursuit. J Pers Soc Psychol. 1997;73(1):186.

    Article  Google Scholar 

  52. Lally P, Gardner B. Promoting habit formation. Health Psychol Rev. 2013;7(sup1):S137–S58.

    Article  Google Scholar 

  53. Cohen SM. Concept analysis of adherence in the context of cardiovascular risk reduction. Nurs Forum. 2009;44(1):25–36.

    Article  PubMed  Google Scholar 

  54. Horne R, Parham R, Driscoll R, Robinson A. Patients’ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(6):837–44.

    Article  PubMed  Google Scholar 

  55. El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268–79.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Horne R, Weinman J. The theoretical basis of concordance and issues for research. In: Bond C, editor. Concordance: a partnership in medicine-taking. London: Pharmaceutical Press; 2004.

    Google Scholar 

  57. Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015;17(2):e52.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Behavioural Medicine, Department of Practice and Policy, UCL School of Pharmacy, University College London, London, UK

    Amy Chan & Rob Horne

Authors
  1. Amy Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rob Horne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rob Horne .

Editor information

Editors and Affiliations

  1. Service of Nephrology and Hypertension, CHUV, University of Lausanne, Lausanne, Vaud, Switzerland

    Michel Burnier

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chan, A., Horne, R. (2018). Beliefs and Adherence in Hypertension and Cardiovascular Protection. In: Burnier, M. (eds) Drug Adherence in Hypertension and Cardiovascular Protection. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-76593-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-76593-8_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-76592-1

  • Online ISBN: 978-3-319-76593-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation